CO4990947A1 - Antibioticos cefalosporinicos - Google Patents
Antibioticos cefalosporinicosInfo
- Publication number
- CO4990947A1 CO4990947A1 CO98073442A CO98073442A CO4990947A1 CO 4990947 A1 CO4990947 A1 CO 4990947A1 CO 98073442 A CO98073442 A CO 98073442A CO 98073442 A CO98073442 A CO 98073442A CO 4990947 A1 CO4990947 A1 CO 4990947A1
- Authority
- CO
- Colombia
- Prior art keywords
- phenyl
- alkyl
- hydrogen
- independently
- cephalosporinic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Abstract
Un Compuesto de fórmula IEn la que:Ra , Rb , Rc , Rd y Re son independientemente H, F o un grupo (alquiloC1 -C6 )-(Z)n - que tiene por lo menos un flúor como sustituyente, X es O o S, Y es S, O o -CH2 -, Z es O, S, -SO- o -SO2 -,m y n son independientemente 0 ó 1,R es Y R1 es H, alquilo C1 -C6 , fenilo o bencilo, cada uno de los cuales puede tener opcionalmente hasta tres sustituyentes seleccionados de halo, alcoxi C1 -C4 , fenilo, NO2 , alcanoílo C1 -C6 , benzoílo o alcanoiloxi C1 -C6 ;O una sal aceptable fisiológicamente del mismo;Con la condición de que :1) por lo menos uno de Ra , Rb , Rc , Rd o Re es distinto de hidrógeno y 2) cuando X e Y son S, y Rb o Rc es F, entonces uno de los restantes Ra , Rb , Rc , Rd o Re es distinto de hidrógeno.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6965597P | 1997-12-12 | 1997-12-12 | |
US8364698P | 1998-04-30 | 1998-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4990947A1 true CO4990947A1 (es) | 2000-12-26 |
Family
ID=26750285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98073442A CO4990947A1 (es) | 1997-12-12 | 1998-12-10 | Antibioticos cefalosporinicos |
Country Status (9)
Country | Link |
---|---|
US (1) | US6329363B1 (es) |
EP (1) | EP0922705A1 (es) |
JP (1) | JP2002508381A (es) |
AR (1) | AR017837A1 (es) |
AU (1) | AU1719099A (es) |
CA (1) | CA2314139A1 (es) |
CO (1) | CO4990947A1 (es) |
PE (1) | PE133899A1 (es) |
WO (1) | WO1999031110A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3056497B1 (en) | 2008-05-05 | 2018-08-29 | The General Hospital Corporation | Methods using bodipy-labelled enzyme substrates |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3335136A (en) | 1965-12-27 | 1967-08-08 | Lilly Co Eli | Halophenylmercaptomethyl cephalosporins |
BE793310A (fr) | 1971-12-27 | 1973-06-27 | Lilly Co Eli | Procede de lutte contre staphylococcus aureus resistant a la methicilline |
CA1017325A (en) | 1971-12-27 | 1977-09-13 | George W. Huffman | Halogenated phenylthioacetamidocephalosporin derivatives |
GB1325846A (en) * | 1972-02-23 | 1973-08-08 | Lilly Co Eli | Process for the preparation of a 3-thiomethyl cephalosporin |
US3907784A (en) * | 1972-09-11 | 1975-09-23 | Lilly Co Eli | 7-Halophenylthioacetamido cephalosporins |
US4261991A (en) * | 1979-05-01 | 1981-04-14 | Eli Lilly And Company | Method of treating infections caused by Streptococcus faecalis |
US4379739A (en) * | 1980-03-31 | 1983-04-12 | Eli Lilly And Company | Electrolytic reduction of cephalosporin p-nitrobenzyl esters |
EP0308558A1 (en) | 1987-09-25 | 1989-03-29 | Mobil Oil Corporation | A process for preparing a macrostructural unit having a catalytically-active zeolite surface |
GB8722477D0 (en) * | 1987-09-24 | 1987-10-28 | Beecham Group Plc | Compounds |
DE69016719T2 (de) | 1989-09-04 | 1995-06-01 | Beecham Group Plc | Cephalosporinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate und Zwischenverbindungen. |
MY106991A (en) | 1989-09-04 | 1995-08-30 | Pfizer | Novel cephalosporin derivatives or compounds |
US5559108A (en) | 1994-09-02 | 1996-09-24 | Bristol-Myers Squibb Company | Cephalosporin derivatives |
US5567698A (en) | 1995-02-15 | 1996-10-22 | Bristol-Myers Squibb Company | Pyridinium thiomethyl substituted chepholosporin derivatives |
-
1998
- 1998-11-06 US US09/188,783 patent/US6329363B1/en not_active Expired - Fee Related
- 1998-12-07 PE PE1998001191A patent/PE133899A1/es not_active Application Discontinuation
- 1998-12-08 JP JP2000539033A patent/JP2002508381A/ja not_active Withdrawn
- 1998-12-08 AU AU17190/99A patent/AU1719099A/en not_active Abandoned
- 1998-12-08 CA CA002314139A patent/CA2314139A1/en not_active Abandoned
- 1998-12-08 WO PCT/US1998/026115 patent/WO1999031110A1/en active Search and Examination
- 1998-12-10 EP EP98310126A patent/EP0922705A1/en not_active Withdrawn
- 1998-12-10 AR ARP980106269A patent/AR017837A1/es unknown
- 1998-12-10 CO CO98073442A patent/CO4990947A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US6329363B1 (en) | 2001-12-11 |
AR017837A1 (es) | 2001-10-24 |
PE133899A1 (es) | 2000-01-11 |
WO1999031110A1 (en) | 1999-06-24 |
EP0922705A1 (en) | 1999-06-16 |
AU1719099A (en) | 1999-07-05 |
CA2314139A1 (en) | 1999-06-24 |
JP2002508381A (ja) | 2002-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003062259A3 (en) | Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents | |
PE20040688A1 (es) | Inhibidores de quinasas | |
AR006390A1 (es) | Derivados de lactama | |
TR199902400T2 (xx) | Fungusit etkinlik g�steren terkiplerin birle�imleri. | |
AR034282A1 (es) | Derivados de difenilazetidinona, medicamentos que contienen estos compuestos, procedimiento para su preparacion, y su utilizacion para la preparacion de medicamentos | |
AR025225A1 (es) | Feniloxazolidinonas heterociclicas biciclicas sustituidas antibacterianas y composiciones farmacéuticas | |
NO20003930D0 (no) | Sammensetninger som inneholder organiske forbindelser | |
NO20013379L (no) | 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler | |
FI962800A0 (fi) | Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina | |
ES2096560T3 (es) | Compuestos de benzocicloheptapiridina sustituida con fluor, composiciones y metodos para uso como compuestos antihistaminicos. | |
FR2619111B1 (fr) | Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique | |
AR002012A1 (es) | Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto. | |
AR036472A1 (es) | Derivados de azetidina, procedimientos para su preparacion y su empleo como agentes pesticidas | |
DE60318826D1 (de) | Alkoxypyridinderivate | |
ATE180781T1 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
EA200000975A1 (ru) | 6-(2-гало-4-алкоксифенил)триазолпиримидины с фунгицидным действием | |
ATE70056T1 (de) | Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen. | |
DE69839781D1 (en) | Heterocyclische topoisomerase toxine | |
PT1089625E (pt) | Agentes ectoparasiticidas | |
NO20004273L (no) | Streptograminderivater, deres fremstilling samt preparater inneholdende forbindelsene | |
DE50101861D1 (de) | Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung | |
CO4650039A1 (es) | Benzotiofenos amorfos, procedimientos de preparacion y procedimientos de uso | |
CO4990947A1 (es) | Antibioticos cefalosporinicos | |
CO5080761A1 (es) | Inhibidores de lad fkbp na inhibidores de las fkbp | |
BR1100967A (pt) | Composto, e, composição farmacêutica |